115 related articles for article (PubMed ID: 10605951)
1. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Fontes Ribeiro CA; Antunes F; Teixeira F
Thromb Res; 1999 Dec; 96(5):365-72. PubMed ID: 10605951
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation is increased in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Rito LC; Teixeira HM; Santos Dias JD; Ferrer-Antunes C; Mesquita JF; Teixeira F
J Cardiovasc Pharmacol; 2000 Jul; 36(1):56-64. PubMed ID: 10892661
[TBL] [Abstract][Full Text] [Related]
3. The distribution of catecholamines between plasma and platelets in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Teixeira F
Pharmacol Res; 2000 Feb; 41(2):129-35. PubMed ID: 10623480
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
Manninen A
Pharmacol Toxicol; 1996 Jun; 78(6):387-91. PubMed ID: 8829198
[TBL] [Abstract][Full Text] [Related]
5. Curative isosorbide-5-mononitrate treatment, in opposition to the beneficial preventive one, aggravates the prothrombotic and proconstrictor state in cyclosporine-induced hypertensive rats.
Reis F; Ponte L; Rocha L; Teixeira-Lemos E; Almeida L; Alcobia T; Lourenço M; Palmeiro A; Ferrer-Antunes CA; Costa-Almeida C; Teixeira F
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):640-8. PubMed ID: 16120191
[TBL] [Abstract][Full Text] [Related]
6. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
7. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
Reis F; Teixeira de Lemos E; Almeida L; Parada B; Garrido AP; Rocha-Pereira P; Santos-Silva A; Santos-Dias J; Dinis A; Figueiredo A; Costa-Almeida C; Mota A; Teixeira F
Transplant Proc; 2007 Oct; 39(8):2501-6. PubMed ID: 17954158
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide-5-mononitrate treatment prevents cyclosporin A-induced platelet hyperactivation and the underlying nitric oxide-cyclic guanosine-3',5'-monophosphate disturbances.
Reis F; Almeida L; Alcobia T; Santos-Dias JD; Lourenço M; Palmeiro A; Ferrer-Antunes CA; Mesquita JF; Pontes F; Teixeira F
Thromb Res; 2003 May; 110(2-3):107-15. PubMed ID: 12893025
[TBL] [Abstract][Full Text] [Related]
9. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
Norris LA; Devitt M; Bonnar J
Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A affects serotonergic mechanisms in uremic rats.
Krygicz D; Azzadin A; Pawlak R; Małyszko JS; Pawlak D; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(3):351-4. PubMed ID: 9112676
[TBL] [Abstract][Full Text] [Related]
11. The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
Mysliwiec J; Azzadin A; Chabielska E; Takada A; Mysliwiec M; Buczko W
Thromb Res; 1996 Jul; 83(2):175-81. PubMed ID: 8837316
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
13. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
[TBL] [Abstract][Full Text] [Related]
14. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen.
Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
J Biochem; 1985 Oct; 98(4):1063-8. PubMed ID: 3001036
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporin A on platelet aggregation and thromboxane/prostacyclin balance in a model of extrahepatic cholestasis in the rat.
González-Correa JA; De La Cruz JP; Lucena MI; Sánchez de la Cuesta F
Thromb Res; 1996 Feb; 81(3):367-81. PubMed ID: 8928094
[TBL] [Abstract][Full Text] [Related]
18. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
Mihara S; Fujimoto M; Okabayashi T
Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A enhances platelet aggregation.
Grace AA; Barradas MA; Mikhailidis DP; Jeremy JY; Moorhead JF; Sweny P; Dandona P
Kidney Int; 1987 Dec; 32(6):889-95. PubMed ID: 3323604
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets.
Li S; Li X; Li J; Deng X; Li Y
Steroids; 2007 Nov; 72(13):875-80. PubMed ID: 17825336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
